{
  "docId": "019dd923-5fed-74f2-a96f-364382cb2b75",
  "docSlug": "bi-dc35af3bd0eea4cf",
  "documentTitle": "HMNC Brain Health pitch deck: $14 million for precision treatments",
  "authorId": "Pitchdecks",
  "authorName": "HMNC Brain Health",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 5,
  "pageCount": 12,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Uses a before-after framing to illustrate the shift from undifferentiated treatment to precision medicine.",
  "elementsJson": [
    "headline_text",
    "action_title",
    "paragraph",
    "infographic",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fed-74f2-a96f-364382cb2b75/5",
  "deckHref": "/decks/019dd923-5fed-74f2-a96f-364382cb2b75",
  "deckJsonHref": "/decks/019dd923-5fed-74f2-a96f-364382cb2b75.json",
  "deckAnchorHref": "/decks/019dd923-5fed-74f2-a96f-364382cb2b75#slide-5",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "HMNC develops proprietary genetic companion diagnostic (CDx) tests that identify major depressive disorder (MDD) patients that are more likely to respond to specific antidepressants.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-cb16-77cb-9961-4e2b9e294172",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.8,
        "w": 0.65,
        "x": 0.35,
        "y": 0.15
      },
      "kind": "framework",
      "text": "AS IS vs OUR VISION",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ba233912-54b9-4604-9d25-a2bebe3c690e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.2,
        "x": 0.58,
        "y": 0.18
      },
      "kind": "image",
      "text": "Icon grid showing undifferentiated patient population",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6bb0f146-bf8f-4411-9e3d-dc4e8e2d8ca3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.6,
        "x": 0.38,
        "y": 0.55
      },
      "kind": "image",
      "text": "Diagram showing patient segmentation via CDx A, B, and C",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cb061087-8370-4793-ab43-60f4f11e8434",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.3,
        "x": 0.03,
        "y": 0.45
      },
      "kind": "paragraph",
      "text": "HMNC develops proprietary genetic companion diagnostic (CDx) tests that identify major depressive disorder (MDD) patients that are more likely to respond to specific antidepressants.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "781a3989-8d9a-4a76-83a2-5b00e48ee95b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.28,
        "x": 0.03,
        "y": 0.225
      },
      "kind": "title",
      "text": "RESHAPING MENTAL HEALTH THERAPY",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "51104278-d228-4cb4-93d2-a7e8d14dd7e3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.75,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "HMNC CO-DEVELOPS RX AND CDX TO IDENTIFY PATIENTS MOST LIKELY TO BENEFIT FROM SPECIFIC TREATMENTS",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "963d53b6-5578-4e98-84f8-f2b15af9a1ec",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before-After-Bridge",
      "slug": "before-after-bridge",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "0f1dbb9b-8a01-4034-a43d-2200fe407913",
      "evidence": "The slide shows a contrast between the current state ('AS IS') and the proposed solution ('OUR VISION').",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "0502666f-03c7-4f43-a52e-db2984f86911",
      "evidence": "Contrasts 'AS IS' (one size fits all) with 'OUR VISION' (precision psychiatry)",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 5,
      "from": 5,
      "beatId": "eaf1e44b-2632-41ef-9f54-4b9a798e3a1d",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Reshaping mental health therapy through precision psychiatry",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "723e4b79-0471-4e54-9684-ccd3140a0b94",
      "evidence": "Problem statement and traction",
      "position": 0,
      "objective": "Highlighting the cost of not adopting precision psychiatry",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}